Many trials lack stratification based on ejection fraction, hindering the ability to determine the differential effects of GLP-1RAs in various heart failure subtypes
The medication is available as a pre-filled pen (Ozempic/Wegovy) or as a compounded vial formulation
Presented for research literature review only Geraldine P et al
Diabetes Care 36, 19331940.CrossRefGoogle ScholarPubMed Scott, RA, Freitag, DF, Li, L, Chu, AY, Surendran, P, Young, R, Grarup, N, Stanckov, A, Chen, Y, Varga, TV and Yaghootkar, H (2016) A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Now, for the first time in a long time, real downward pressure on prices is starting to show up
In standard oral or liposomal doses, glutathione is not associated with significant kidney side effects